Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gen Digital Inc. Common Stock (GEN) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Gen Digital Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Gen Digital Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Gen Digital Inc. Common Stock trades at $23.77 (market cap $14.24B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Gen Digital Inc. Common Stock is far larger — about 7.9× Vir Biotechnology Inc. Common Stock's market cap, and Gen Digital Inc. Common Stock pays a 2.1% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gen Digital Inc. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

GENVIR
Market Cap
$14.24B$1.80B
Volume
6,202,6991,782,836
Sector
TechnologyHealth
52-Week High
$31.41$11.78
52-Week Low
$17.89$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$21.89B$1.36B
Dividend Yield
2.1%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gen Digital Inc. Common Stock

GEN Digital Inc. (GEN) trades at $23.81, up 1.97% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 13.92, net income margin of 20.73%, and robust cash flow from operations of $1.22B in 2025. Recent news highlights include a takeover bid for GoDaddy and participation in investor conferences, reflecting strategic moves in the cybersecurity and digital services sector.

The outlook is mixed: analyst consensus targets $25.50 with a balanced buy/hold split, but technical indicators suggest near-term pressure. Key risks include high debt levels and integration challenges from acquisitions. Earnings growth and market expansion into AI services present opportunities, though volatility may persist amid competitive and macroeconomic headwinds.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEN

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Gen Digital Inc. Common Stock

Gen Digital provides cybersecurity, online privacy, identity protection, and financial wellness services. Its consumer brands include Norton, Avast, LifeLock, and MoneyLion.

Read more on GEN →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →